Search - tctmd.com

Displaying 481 - 500 of 557

Sort: Relevancy | Date

News Daily News

Female-Specific Data Lacking for Myocardial Revascularization: SCAI

Todd Neale

February 08, 2022

News Conference News THT 2022

Xenotransplant of Pig Heart ‘Just Baby Steps,’ Lead Surgeon Says

Yael L. Maxwell

February 07, 2022

News Conference News THT 2022

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

Caitlin E. Cox

February 07, 2022

News Daily News

COVID-19: TCTMD’s Dispatch for February Week 2

Todd Neale

February 07, 2022

News Conference News THT 2022

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

L.A. McKeown

February 07, 2022

News Conference News STS 2022

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Michael O'Riordan

February 04, 2022

News Opinion Off Script

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Charles C. Hong, MD, PhD

February 04, 2022

News Conference News STS 2022

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

Yael L. Maxwell

February 03, 2022

News Conference News STS 2022

Modified Surgical MV Repair Stands Up to Replacement

Michael O'Riordan

February 03, 2022

News Conference News THT 2022

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

L.A. McKeown

February 03, 2022

News Daily News

SCAI-Defined Perioperative MIs Too Numerous to Be Useful in Cardiac Surgery

Michael O'Riordan

February 03, 2022

Presentation Miami Valves 2022

TAVR: Where to Now? My Crystal Ball for the next Decade

Presenter: Eberhard Grube

February 03, 2022

News Conference News THT 2022

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Caitlin E. Cox

February 02, 2022

News Conference News STS 2022

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

Todd Neale

February 02, 2022

News Conference News STS 2022

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

L.A. McKeown

February 02, 2022

News Industry News

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

February 02, 2022

Presentation THT 2022

scPharma

Presenter: Daniel Bensimhon

February 01, 2022

Presentation THT 2022

WhiteSwell

Presenter: Sitaramesh Emani

February 01, 2022

Presentation THT 2022

3ive

Presenter: David Baran

February 01, 2022

Presentation THT 2022

Cardionomic

Presenter: Sitaramesh Emani

February 01, 2022

Advertisement

Female-Specific Data Lacking for Myocardial Revascularization: SCAI

Xenotransplant of Pig Heart ‘Just Baby Steps,’ Lead Surgeon Says

Cardiogenic Shock’s Origins, Progression Tightly Tied to Mortality

COVID-19: TCTMD’s Dispatch for February Week 2

Probe Beyond Ejection Fraction to Understand and Manage HFpEF

Tricuspid Repair During Mitral Valve Surgery Prevents TR Progression

Heart Failure, Hope, and the Hurdles Ahead for Xenotransplantation

Decades of Real-world Data Affirm Benefit of Multiple Arterial CABG

Modified Surgical MV Repair Stands Up to Replacement

PA Pressure Monitoring Useful Even in Presymptomatic CHF Patients

SCAI-Defined Perioperative MIs Too Numerous to Be Useful in Cardiac Surgery

TAVR: Where to Now? My Crystal Ball for the next Decade

LAVA ECMO: Early Data Point to Hemodynamic Benefits, Safety

Transcatheter Mitral Valve-in-Valve a ‘Good Option’, but With Higher Gradients

Bicuspid SAVR Outcomes Meet or Beat Tricuspid in STS Database

Landmark REDUCE LAP-HF II Trial Demonstrates Clinical Benefit of Corvia Atrial Shunt in Large Segment of Heart Failure Patients

scPharma

WhiteSwell

3ive

Cardionomic

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content